Bosede B. Afolabi

Lagos, LA, Nigeria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 87 publications

Intravenous ferric carboxymaltose versus oral ferrous sulphate for iron deficiency anaemia in pregnancy in Nigeria: a cost-utility analysis.

Intravenous ferric carboxymaltose versus oral ferrous sulphate for iron deficiency anaemia in pregnancy in Nigeria: a cost-utility analysis.

Journal: The Lancet. Obstetrics, gynaecology, & women's health

Published: June 25, 2026

Improving maternal and neonatal outcomes in low-income communities in lagos state, Nigeria: an overview of the mamabase pilot program.

Improving maternal and neonatal outcomes in low-income communities in lagos state, Nigeria: an overview of the mamabase pilot program.

Journal: Frontiers in global women's health

Published: April 04, 2026

Azithromycin use in labour to prevent sepsis among pregnant women undergoing vaginal delivery in Nigeria (AZIN-V): a study protocol for a hybrid type 2 effectiveness-implementation trial.

Azithromycin use in labour to prevent sepsis among pregnant women undergoing vaginal delivery in Nigeria (AZIN-V): a study protocol for a hybrid type 2 effectiveness-implementation trial.

Journal: BMJ open

Published: February 06, 2026

Inter-facility travel time and referral for emergency obstetric care in the 15 most populated cities of Nigeria: a spatial analysis.

Inter-facility travel time and referral for emergency obstetric care in the 15 most populated cities of Nigeria: a spatial analysis.

Journal: BMC global and public health

Published: January 29, 2026

Correction: Patterns of utilization and determinants of maternal health services among women residing in low-income communities in Lagos State, Nigeria.

Correction: Patterns of utilization and determinants of maternal health services among women residing in low-income communities in Lagos State, Nigeria.

Journal: PLOS global public health

Published: December 22, 2025

Implementing intravenous iron for maternal anemia in Nigeria: A qualitative study of healthcare provider experiences using the normalization process theory.

Implementing intravenous iron for maternal anemia in Nigeria: A qualitative study of healthcare provider experiences using the normalization process theory.

Journal: PloS one

Published: November 04, 2025

Integrating a single-dose intravenous iron therapy (ferric carboxymaltose) for maternal anaemia in Nigeria: Insights from stakeholder engagement.

Integrating a single-dose intravenous iron therapy (ferric carboxymaltose) for maternal anaemia in Nigeria: Insights from stakeholder engagement.

Journal: Journal of public health in Africa

Published: September 15, 2025

Maternal screening coverage and determinants during facility-based antenatal care in Nigeria: analysis of the 2018 Demographic and Health Survey.

Maternal screening coverage and determinants during facility-based antenatal care in Nigeria: analysis of the 2018 Demographic and Health Survey.

Journal: Reproductive health

Published: August 29, 2025

Intravenous ferric carboxymaltose versus oral ferrous sulphate for the treatment of moderate-to-severe postpartum anaemia in Nigerian women (IVON-PP): an open-label, randomised controlled trial.

Intravenous ferric carboxymaltose versus oral ferrous sulphate for the treatment of moderate-to-severe postpartum anaemia in Nigerian women (IVON-PP): an open-label, randomised controlled trial.

Journal: The Lancet. Global health

Published: August 22, 2025

Low-dose aspirin for preventing intrauterine growth restriction and pre-eclampsia in sickle cell pregnancy in Nigeria (PIPSICKLE): a randomised controlled trial.

Low-dose aspirin for preventing intrauterine growth restriction and pre-eclampsia in sickle cell pregnancy in Nigeria (PIPSICKLE): a randomised controlled trial.

Journal: The Lancet. Global health

Published: July 30, 2025

New WHO recommendations on the management of sickle-cell disease in pregnancy.

New WHO recommendations on the management of sickle-cell disease in pregnancy.

Journal: Pregnancy (Hoboken, N.J.)

Published: July 15, 2025

Time of onset of pre-eclampsia as a determinant of risk of cardiovascular disease and renal impairment at six weeks post partum: a cohort study in Lagos, Nigeria.

Time of onset of pre-eclampsia as a determinant of risk of cardiovascular disease and renal impairment at six weeks post partum: a cohort study in Lagos, Nigeria.

Journal: BMJ open

Published: July 15, 2025

Showing 1-12 of 87

Last Updated: 09/26/2026